Investors locked in profits on Amarin Corp. (Nasdaq: AMRN). Shares of the biopharmaceutical fell 41 cents to $2.44.
Profit taking weighs down Amarin
March 17, 2015 at 13:26 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|